JAMA: Journal of the American Medical Association

JAMA, which has been in publication since 1883, is a global, peer-reviewed medical journal that releases new issues every week both online and in print. It holds the title of the most widely distributed medical journal globally. The online edition is accessible for free to institutions located in developing nations. The current Editor-in-Chief is Dr. Howard Bauchner.

National

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#15103

United States

#5352

Health/Medicine

#56

Traffic sources

Monthly visitors

Articles

Has This Child Experienced Physical Abuse? A Systematic Review

3 days ago | jamanetwork.com | Sonal Shah

The Rational Clinical Examination Has This Child Experienced Physical Abuse?The Rational Clinical Examination Systematic Review US Preventive Services Task Force USPSTF Recommendation: Primary Care Interventions to Prevent Child Maltreatment US Preventive Services Task Force; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Silverstein, MD, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M.
Anti-Vascular Endothelial Growth Factor Options and Questions for Diabetic Eye Disease Treatment

1 week ago | jamanetwork.com | Adam Glassman

Anti–Vascular Endothelial Growth Factor Options and Questions for Diabetic Eye Disease Treatment Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab Arshad M. Khanani, MD; Peter A. Campochiaro, MD; Jordan M. Graff, MD; Dennis M. Marcus, MD; Daniel Miller, MD; Robert A. Mittra, MD; Carl Regillo, MD; Veeral S.
Evidence-Informed Quality Indicators for Pediatric Trauma Care

1 week ago | jamanetwork.com | Lynne Moore |Université Laval |Natalie Yanchar |Matthew Weiss

Importance Despite the unique physiological characteristics and health care needs of pediatric trauma patients, there is a lack of quality indicators (QIs) based on pediatric-specific evidence to support quality improvement in this population. Objective To develop a consensus-based set of QIs for acute pediatric trauma care that considers evidence on effectiveness, safety, cost-effectiveness, equity, and caregiver perspectives and is applicable in pediatric and nonpediatric trauma centers.
Is Staphylococcus Aureus Still a Problem in the Neonatal Intensive Care Unit?

1 week ago | jamanetwork.com | Lakshmi Srinivasan |David Kaufman

[Skip to Navigation] PDF Full Text Share X Facebook Email LinkedIn Cite Permissions April 14, 2025 JAMA Pediatr. Published online April 14, 2025.
Development, Validation, and Valuation of a Head and Neck Cancer−Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study | Head and Neck Cancer | JAMA Otolaryngology-Head & Neck Surgery | JAMA Network

1 week ago | jamanetwork.com | Temerty Faculty |Matthias Büttner |David J. Goldstein |Aaron R. Hansen

Importance Generic health utility instruments lack the discriminative ability to differentiate among health states in patients after head and neck cancer treatment. Objective To develop, validate, and valuate a head and neck cancer−specific health utility measure. Design, Setting, and Participants This psychometric study comprised 2 phases to develop and validate a health utility instrument. The first phase, development and validation, occurred from January 2021 to August 2022.
New International Editorial Board Member-February 2025

1 week ago | jamanetwork.com | Melina Kibbe

JAMA Surgery would like to thank Avery B. Nathens, MD, MPH, PhD, for his extraordinary service and contributions to the journal as a member of the International Editorial Board for the past 10 years. Effective February 1, 2025, JAMA Surgery is excited to announce the appointment of María F. Jiménez, MD, to the International Editorial Board. María F.
Cost of Neoadjuvant Immunotherapy vs Up-Front Surgery in Cutaneous Squamous Cell Carcinoma: A Post Hoc Analysis of a Nonrandomized Clinical Trial

1 week ago | jamanetwork.com | Shannon Wu |Luis Ramirez |Luis Ramírez |Michelle Chen

Importance There is increasing interest in use of neoadjuvant immunotherapy (NAT) in advanced cutaneous squamous cell carcinoma (cSCC) to reduce surgical morbidity and forego adjuvant therapy, while potentially improving survival outcomes. Objective To assess the cost to Medicare of NAT compared with up-front surgery. Design, Setting, and Participants This cohort study was a post hoc analysis of a phase 2 clinical trial evaluating the feasibility of neoadjuvant atezolizumab.
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment

1 week ago | jamanetwork.com | Ifrah Zawar |Mark Quigg |Emily Johnson |Johns Hopkins

Importance The risk of developing epilepsy substantially increases after the age of 60 years (late-onset epilepsy [LOE]), particularly in people with cognitive decline ([PWCD] ie, dementia and/or mild cognitive impairment). Epilepsy is associated with worse cognitive and mortality outcomes in PWCD. Identifying PWCD at risk for developing LOE can facilitate early screening and treatment of epilepsy. Objective To investigate factors associated with LOE in PWCD.
Why Good Palliative Care Clinicians Get Fired

1 week ago | jamanetwork.com | Abby R. Rosenberg |Elliot Rabinowitz |Robert Arnold

[Skip to Navigation] PDF Full Text Share X Facebook Email LinkedIn Cite Permissions April 14, 2025 JAMA. Published online April 14, 2025.
How Dismantling DEI Efforts Could Make Clinical Trials Less Representative

1 week ago | jamanetwork.com | Rita Rubin |Lead Senior

It’s been nearly 30 years since Congress, in the Food and Drug Administration (FDA) Modernization Act of 1997, instructed the US Health and Human Services (HHS) secretary to consult with the National Institutes of Health (NIH) director and the pharmaceutical industry to “review and develop guidance, as appropriate, on the inclusion of women and minorities in clinical trials…” In recent weeks, though, such guidance documents and other information about enrolling patients long underrepresented...